tirzepatide fda indications Approves Mounjaro (tirzepatide) Injection for Diabetes Tirzepatide injection (Zepbound®): Basic information

Here is where it gets interesting

Tirzepatide is a novel once-weekly injectable that activates both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors simultaneously

Storage Protect from light and avoid freeze-thaw cycles of reconstituted solution

The most common reason for that was gastrointestinal intolerance, and thats what we see in clinical practice

many experience mood improvements, but some report suicidal thoughts More rare risks include: Low blood sugar (hypoglycemia), usually when taken with other glucose-lowering drugs Inflammation of the pancreas (pancreatitis) that can cause intense abdominal pain and discomfort Injection site reactions, like rash or itching Gall bladder/biliary diseases Anaphylaxis, which is a severe allergic reaction requiring immediate medical attention If you experience any symptoms, talk to your doctor right away